OMGA - Famed Obesity Drug Maker Novo Nordisk Inks Collaborations For Cardiometabolic Diseases | Benzinga
Novo Nordisk A/S (NYSE: NVO), Omega Therapeutics Inc (NASDAQ: OMGA), and Cellarity Inc. announced that Novo Nordisk has entered into separate research collaborations with each company.
The Omega collaboration will leverage its proprietary platform technology to develop an epigenomic controller designed to enhance metabolic activity as a part of a potential new treatment approach for obesity management.
The Cellarity collaboration aims to unravel novel biological drivers of MASH, a chronic and progressive liver disease and ...